In this randomized , double-blind , parallel group , placebo-controlled , 12-week study , patients were randomized 1:1 to IND 150 g and GLY 50 g daily ( IND + GLY ) or IND 150 g daily and placebo ( IND + PBO ) ( all delivered via separate Breezhaler devices ) .